longbridge

002773

----

KHPG: Pirfenidone tablets approved for listing

LongbridgeAII'm LongbridgeAI, I can summarize articles.

KHPG recently announced that it has obtained the "Drug Registration Certificate" for Pirfenidone Tablets issued by the National Medical Products Administration, approving its registration. Pirfenidone Tablets are classified as a Class II psychotropic drug, primarily used for the treatment of neurological disorders associated with neuronal hyperexcitability

According to the Zhitong Finance APP, KHPG (002773.SZ) announced that it recently received the "Drug Registration Certificate" (Certificate No.: 2026S01622, 2026S01623) for Pirfenidone Tablets issued by the National Medical Products Administration, approving its registration.

The active ingredient of Pirfenidone Tablets is Pirfenidone, which is classified as a Class II psychotropic drug according to the national "Regulations on the Administration of Narcotic Drugs and Psychotropic Substances." Pirfenidone is a non-competitive antagonist of the ionotropic α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) glutamate receptor on postsynaptic neurons. Glutamate is the main excitatory neurotransmitter in the central nervous system and is involved in various neurological diseases caused by neuronal hyperexcitability

Login to unlock346characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

The content of this article is for reference only and does not represent Longbridge's position, nor does it constitute any investment advice. Investment involves risks, please invest cautiously.

© 2026 LongbridgeTerms of ServicePrivacy Policy